Statewide quality improvement project reduced excessive radiation treatments for bone metastases by 80%

The effort by the Michigan Radiation Oncology Quality Consortium reduced unnecessary medical procedures, and saved the time and resources of patients and families.

10:19 PM

Author | Ian Demsky

doctor in white coat scanning person in machine with words "lab note" written on yellow badge with blue font bottom right
Michigan Medicine

An effort by the Michigan Radiation Oncology Quality Consortium reduced excessive radiation treatments for bone metastases by 80% at health care centers across the state, according to findings published in Practical Radiation Oncology.

The two-year project focused on reducing the use of extended-fraction radiation therapy to treat pain from incurable cancer that had spread to patients' bones. Once a standard practice, the American Society for Radiation Oncology has recommended against the routine use of extended-fraction radiation to relieve pain from bone metastases, especially more than 10 treatments.

"The goal was to save medical resources as well as reduce the burden on patients," said study first author Elizabeth Jaworski, M.D., a house officer in the Department of Radiation Oncology at U-M. "Patients and their loved ones may have to miss work to get these treatments. There may be travel costs, parking costs — it all adds up. And studies have found that getting more treatments isn't likely to lower their cancer pain any better."

The Michigan Radiation Oncology Quality Consortium, a collaborative quality initiative funded by Blue Cross Blue Shield of Michigan and the Blue Care Network, made a push across its member sites to reduce the procedures in 2018. By the fall of 2020, the use of extended-fraction for bone metastases fell from nearly 15% to just over 3% at 28 radiation facilities across the state.

More extended treatment was likely to happen at non-teaching hospitals and among physicians who had been practicing longer, the study of more than 1,400 patients found.

"We were very pleased to see this effort have such an impact in Michigan. In some parts of the country, use is still higher than 15%," said senior study author James Hayman, M.D., M.B.A., a radiation oncologist at U-M and co-director of the quality consortium. "And, while more than 10 treatments may be appropriate in rare cases, we're continuing to look at ways to reduce the overall number of treatments even further."

Paper cited: "Contemporary practice patterns for palliative radiotherapy of bone metastases: Impact of a quality improvement project on extended fractionation," Practical Radiation Oncology. DOI: 10.1016/j.prro.2021.05.002

More Articles About: Lab Notes Radiation Oncology Cancer Treatment Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories women doc looking ay xray up on bright board
Health Lab
Simple changes in care reduced heart exposure during lung cancer radiation treatment
By raising awareness about the correlation between increased radiation exposure and cardiac events, average doses were reduced without minimizing cancer treatment. 
woman putting something in vial in lab coat and purple gloves, glasses and mask in clinical looking area
Health Lab
Altering cancer treatment dosing could reduce climate impact, study finds
Changing how often a popular cancer therapy is delivered would reduce greenhouse gas emissions and improve environmental impact without decreasing cancer survival, according to a new analysis from researchers at the University of Michigan Health Rogel Cancer Center.
Cancer Aware
Palliative Care vs Hospice Care
On this episode of Cancer Aware, we are talking with Maria Silveira who is a palliative care specialist at Michigan Medicine and the Ann Arbor Veterans Affairs. She has over 20 years of experience working in the hospital and in clinic, taking care of patients with serious illness, supporting them and their families through what is often the toughest time of their lives. She helps train the next generation of palliative care and hospice physicians and nurse practitioners, and she does research in symptom management.
cancer cell blue yellow
Health Lab
Widening inequality seen where cancer clinical trials are available
The availability of clinical trials of new treatments for cancer varies greatly by geography, and a new study shows more socially vulnerable areas have far fewer.
stained glass green blue purple orange pink
Health Lab
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment
A study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas.
Scientific illustration of gliobastoma cells in the brain
Health Lab
Path forward for glioblastoma treatment
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment